/

iRhythm Technologies, Inc.

IRTC US

IRTC USiRhythm Technologies, Inc.

United States Composite

109.00

USD

-2.74

(-2.45%)

-4.04EPS Dil.

-26.96P/E

3.37BMarket Cap

Next Earnings

May 2

Held by Insiders

1.06%

Held by Institutions

108.91%

Short % of Float

5.81%

YTD Yield

-12.83%

3Y Yield

45.93%

5Y Yield

49.13%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

LT Borrowings

LT Finance Leases

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

3,187

2,887

3,313

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

242

234

231

Cash, Cash Equivalents & STI

165

158

134

Accounts Receivable, Net

Inventories

Total Current Liabilities

102

107

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

0.00%

27.72%

19.95%

Net Income, GAAP

-NaN%

-28.09%

-6.03%

Free Cash Flow

-NaN%

-36.85%

-71.70%

Total Cash Common Dividend

- -

Total Equity

-NaN%

53.61%

-12.50%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

323

2022

102

104

113

411

2023

111

124

125

133

493

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

-0.95

-0.59

-0.81

-1.10

-3.46

2022

-1.71

-0.80

-0.71

-0.67

-3.88

2023

-1.29

-0.61

-0.89

-1.26

-4.04

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Company Description

CEO: Mr. Quentin S. Blackford
Full Time Employees: 2,000
Sector: Healthcare
Industry: Medical Devices
Address: 699 8th Street San Francisco CA United States 94103
CIK: 0001388658
Website: www.irhythmtech.com
Business: iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Company News

Yahoo
9 days ago
What Makes iRhythm Technologies (IRTC) a Lucrative Investment?
Yahoo
14 days ago
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
Zacks
25 days ago
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
Yahoo
25 days ago
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
Yahoo
a month ago
Loss-Making iRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-Term
Tipranks
a month ago
Class Action Suit against iRhythm Technologies, Inc. (IRTC)
Tipranks
2 months ago
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)
Yahoo
2 months ago
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
Yahoo
2 months ago
Insider Sell: EVP, CMO & CSO Minang Turakhia Sells 943 Shares of iRhythm Technologies Inc (IRTC)
Yahoo
2 months ago
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
Yahoo
2 months ago
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes

Company Description

CEO: Mr. Quentin S. Blackford
Full Time Employees: 2,000
Sector: Healthcare
Industry: Medical Devices
Address: 699 8th Street San Francisco CA United States 94103
CIK: 0001388658
Website: www.irhythmtech.com
Business: iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Company News

Yahoo
9 days ago
What Makes iRhythm Technologies (IRTC) a Lucrative Investment?
Yahoo
14 days ago
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
Zacks
25 days ago
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
Yahoo
25 days ago
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
Yahoo
a month ago
Loss-Making iRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-Term
Tipranks
a month ago
Class Action Suit against iRhythm Technologies, Inc. (IRTC)
Tipranks
2 months ago
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)
Yahoo
2 months ago
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
Yahoo
2 months ago
Insider Sell: EVP, CMO & CSO Minang Turakhia Sells 943 Shares of iRhythm Technologies Inc (IRTC)
Yahoo
2 months ago
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
Yahoo
2 months ago
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes